William B. O'Connor
2013
In 2013, William B. O'Connor earned a total compensation of $1.1M as Chief Financial Officer at Medicines, a 18% increase compared to previous year.
Compensation breakdown
| Bonus | $23,164 |
|---|---|
| Non-Equity Incentive Plan | $238,125 |
| Option Awards | $146,345 |
| Salary | $375,000 |
| Stock Awards | $342,989 |
| Other | $3,319 |
| Total | $1,128,942 |
O'Connor received $375K in salary, accounting for 33% of the total pay in 2013.
O'Connor also received $23.2K in bonus, $238.1K in non-equity incentive plan, $146.3K in option awards, $343K in stock awards and $3.3K in other compensation.
Rankings
In 2013, William B. O'Connor's compensation ranked 6,080th out of 12,286 executives tracked by ExecPay. In other words, O'Connor earned more than 50.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,080 out of 12,286 | 51st |
Division Manufacturing | 2,119 out of 4,612 | 54th |
Major group Chemicals And Allied Products | 626 out of 1,466 | 57th |
Industry group Drugs | 450 out of 1,160 | 61st |
Industry Pharmaceutical Preparations | 361 out of 890 | 59th |
Source: SEC filing on April 25, 2016.
O'Connor's colleagues
We found three more compensation records of executives who worked with William B. O'Connor at Medicines in 2013.